News about Aeterna Zentaris Inc

Aeterna Zentaris Inc Shows Positive Momentum in Recent Trading Period
Aug 15 2024
Aeterna Zentaris Inc, a specialty biopharmaceutical company, has witnessed notable developments and movements in its stock prices over the past few we...

Innovative Merger: Aeterna Zentaris and Ceapro Unite to Lead Biopharmaceutical Industry
Jun 03 2024
TORONTO and EDMONTON, Alberta, June 03, 2024 - Aeterna Zentaris Inc. and Ceapro Inc. have officially completed their merger transaction, marking a sig...

AEterna Zentaris Inc. Faces Challenges Despite Favorable ISS Recommendation
Mar 30 2024
Aeterna Zentaris Inc., a leading biopharmaceutical development company, has recently received a favorable recommendation from Institutional Shareholde...

Ceapro and Aeterna Merger Receives Final Approval from Court of King*s Bench of Alberta
Mar 28 2024
...

ISS Recommends Shareholders* Approval for Aeterna Zentaris and Ceapro*s Merger, Paving the Way for a Diversified Biopharmaceutical Powerhouse
Feb 26 2024
Leading biopharmaceutical development companies, Aeterna Zentaris Inc. and Ceapro Inc., have received favorable recommendations from Institu...